Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

NICE changes insulin advice in diabetes guidelines

December 12, 2014 Sales and Marketing NHS, NICE, diabetes, health survey, insulin, type 1, type 2

NICE has changed its recommendations on type 1 diabetes in adults and children, and type 2 diabetes in children, to …
News

Unilife appoints comms VP from Intel

December 12, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing kevin sellers, unilife

US developer of injectable drugs Unilife has looked to Intel to appoint a marketing and communications veteran in Kevin Sellers. …
Appointment

Antibiotic resistance could kill 10 million a year

December 11, 2014 Research and Development, Sales and Marketing Antibiotics, Cancer, KPMG, Merck, david cameron, rand

Antibiotic-resistant bacteria will kill an extra 10 million people a year by 2050 if the problem is not tackled soon, …
News

Sanofi looking to diversify, may buy into animal health

December 11, 2014 Manufacturing and Production, Research and Development, Sales and Marketing EFPIA, Jimenez, Sanofi, Serge Weinberg, Viehbacher, animal health

Sanofi is looking to diversify and is even considering buying into the consumer and animal health markets according to its …
News

Takeda eyes new drug licences following positive blood cancer studies

December 11, 2014 Research and Development, Sales and Marketing Adcetris, Takeda, Velcade, ash, bortezomib, brentuximab vedotin, hematology

Takeda is bringing its biotech arm in-house to create a global oncology business unit, which it says will drive forward …
News

Boehringer trials Pradaxa anti-bleeding antidote

December 11, 2014 Sales and Marketing BMS, Bayer, Boehringer, Eliquis, Pradaxa, ash, dabigatran, idarucizumab

Boehringer Ingelheim says that its investigational drug can safely reverse the blood-thinning effect of its anti-clotting drug Pradaxa (dabigatran). The …
News

Mylan shells out $32.5m to cover tax inversion fines

December 11, 2014 Sales and Marketing AbbVie, Abbott, Mylan, SEC, bresch, coury

Mylan will pay five of its top executives an early $32.5 million to cover penalties from the company’s plans to …
News

Tamoxifen found to reduce breast cancer rates by 30%

December 11, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arimidex, NICE, anastrozole, astrazenea, breast cancer, tamoxifen

A study from Queen Mary University has demonstrated that tamoxifen can reduce breast cancer rates by around 30% over 20 …
News

Half of England on prescription drugs

December 11, 2014 Sales and Marketing England, HSCIC, NHS, doctors, prescribing, prescriptions

Almost half of the people in England are taking regular prescription medicines according to a new report by the Health …
News

Kim Lemon named head of Liberation Unlimited

December 11, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston Health, kim lemon, liberation unlimited

Marketing communications agency Liberation Unlimited has appointed Kim Lemon to head its operations. Since the UK-based comms firm joined the …
Appointment

Treatment shifts away from chemotherapy for multiple myeloma

December 10, 2014 Research and Development, Sales and Marketing Kyprolis, carfilzomib, chemotherapy, myeloma, onyx pharmaceuticals

Results from a Phase III study of a new multiple myeloma offering have found promising results for a treatment that …
News

Private firms account for a third of NHS contracts

December 10, 2014 Medical Communications, Sales and Marketing Budget, Cameron, Hunt, NHS, Osborne, autumn, election, privatisation

A large percentage of NHS contracts in England have been awarded to private sector providers since 2013, according to data …
News

Labour to extend cancer drugs funding if elected

December 10, 2014 Research and Development, Sales and Marketing CDF, Cancer, Labour, NHS, NICE, andy burnham, election

Labour has committed to continuing the Cancer Drugs Fund system under the guise of a new £330 million ‘Cancer Treatment …
News

EFPIA gives president role to Novartis chief executive

December 10, 2014 Medical Communications, Sales and Marketing EFPIA, Novartis, Sanofi, Witty, garidel, joe jimenez, oschmann

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has named Novartis chief executive Joe Jimenez as its new president. …
News

Pharnext adds industry veteran to board

December 10, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Michel de Rosen, pharnext

France-based clinical stage biopharma firm Pharnext has appointed Michel de Rosen to its board of directors. For nearly 25 years …
Appointment
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026